![Sanofi on Twitter: "With @Regeneron, we are at #ERSCongress sharing data on the long-term management of asthma and type 2 inflammation biomarkers. Explore the virtual sessions on #asthma to learn more. https://t.co/837ZKB2A0Y" / Sanofi on Twitter: "With @Regeneron, we are at #ERSCongress sharing data on the long-term management of asthma and type 2 inflammation biomarkers. Explore the virtual sessions on #asthma to learn more. https://t.co/837ZKB2A0Y" /](https://pbs.twimg.com/media/EhYEsCIXcAAfM33.jpg)
Sanofi on Twitter: "With @Regeneron, we are at #ERSCongress sharing data on the long-term management of asthma and type 2 inflammation biomarkers. Explore the virtual sessions on #asthma to learn more. https://t.co/837ZKB2A0Y" /
![Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline | European Respiratory Society Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline | European Respiratory Society](https://erj.ersjournals.com/sites/default/files/highwire/erj/55/1.cover-source.jpg)
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline | European Respiratory Society
Clinical Updates in the Management of Severe Asthma by Reynold A. Panettieri, Jr., MD, Michael E. Wechsler, MD, MMSc - Ebook | Scribd
![Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes | European Respiratory Society Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes | European Respiratory Society](https://erj.ersjournals.com/content/erj/59/1/2102730/F4.large.jpg)